I think we're going to see more and more court challenges. Up to last year, the office had never had a court challenge. One was made, and it was resolved. Now two others are in progress.
Judicial review essentially serves as an oversight mechanism for our work. In both challenges, my appointment and impartiality are being questioned and a reasonable decision is being sought. In one case, I decided to drop the Apotex investigation following the death of Mr. Sherman. In the other, I decided not to pursue the Aga Khan investigation because he was not a lobbyist.